image
Acumen Pharmaceuticals, Inc. ABOS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.04
-1.89 %
$ 63 M
Market Cap
-0.54
P/E
Price Target Average
573.08%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
23.09%
Net Income Estimate
--4.46%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Acumen Pharmaceuticals, Inc.
image
Wall Street analysts predict an average 1-year price target for ABOS of $7 , with forecasts ranging from a low of $7 to a high of $7 .
ABOS Lowest Price Target Wall Street Target
7 USD 573.08%
ABOS Average Price Target Wall Street Target
7 USD 573.08%
ABOS Highest Price Target Wall Street Target
7 USD 573.08%
Price
Max Price Target
Min Price Target
Average Price Target
7766554433221100Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25May '25May '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26May '26May '26
REVENUE FORECAST

Revenue Forecast Chart ABOS

image
$60.0m$60.0m$50.0m$50.0m$40.0m$40.0m$30.0m$30.0m$20.0m$20.0m$10.0m$10.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart ABOS

image
$40.0m$40.0m$20.0m$20.0m$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart ABOS

image
$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)($140.0m)($140.0m)20232023202420242025202520262026202720272028202820292029